Tenvir-L Tablets
Brand Name: Tenvir-L Tablets
Composition: Lamivudine (300mg) + Tenofovir Disoproxil Fumarate (300mg)
Quantity: 30 Tablets
Dosing Schedule: Once daily
Manufacturer: CIPLA LTD.
Product Description
Medical Info
Tenvir-L is a vital fixed-dose combination antiretroviral medication engineered by Cipla Ltd. Each tablet integrates two crucial Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs): Lamivudine (300 mg) and Tenofovir Disoproxil Fumarate (300 mg). This synergy is clinically indicated for the management of Human Immunodeficiency Virus Type 1 (HIV-1) infection in adults and adolescents, often serving as a foundational backbone in comprehensive antiretroviral regimens. Designed for a convenient once-daily schedule to optimize patient adherence, Tenvir-L effectively blocks the viral reverse transcriptase enzyme, significantly reducing viral load, slowing disease progression, and supporting overall immune health.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
